Back to Top
Landogrozumab Biosimilar - Research Grade
$710.00 - $6,900.00
Landogrozumab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
MSTNï؟½
Concentration
5mg/ml
Isotype
IgG4 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
O14793
Shipping Conditions
Blue ice
Background
Myostatin (MSTN) is a negative regulator of skeletal-muscle growth, central to studies of muscle wasting and metabolic physiology. Our reagent is an unconjugated, non-therapeutic analog of landogrozumab, a human IgG4, kappa monoclonal that neutralizes the human protein and is distributed for research use only (RUO). It is supplied with low endotoxin to support in vivo experimentation and produced across milligram to gram scales to serve heavy-usage and high-throughput laboratories. The antibody is applied in ligand-neutralization and binding assays, in vitro screening, and preclinical muscle and metabolic disease models, where it functions as a reliable, non-therapeutic control for functional and biologics-characterization studies.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review












